Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Craniospinal RT Followed by Adjuvant Chemotherapy for Newly-Diagnosed Average Risk Medulloblastoma
NCT00002875Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Dec 1996
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of cyclophosphamide in medulloblastoma, sponsored by Children's Oncology Group. Started Dec 1996; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on NCT00002875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002875.